References
- KösterIvon FerberLIhlePSchubertIHaunerHThe cost burden of diabetes mellitus: the evidence from Germany – the CoDiM StudyDiabetologia20064971498150416752168
- MatthaeiSBierwirthRFritscheAMedical antihyperglycaemic treatment of type 2 diabetes mellitus: update of the evidence-based guideline of the German Diabetes AssociationExp Clin Endocrinol Diabetes2009117952255719876795
- OwensDRClinical evidence for the earlier initiation of insulin therapy in type 2 diabetesDiabetes Technol Ther201315977678523786228
- HanefeldMFleischmannHLandgrafWPistroschFEARLY study: early basal insulin therapy under real-life conditions in type 2 diabeticsDiabetes Stoffw Herz20122129197
- ChonSOhSKimSWKimJWKimYSWooJTThe effect of early insulin therapy on pancreatic beta-cell function and long-term glycemic control in newly diagnosed type 2 diabetic patientsKorean J Intern Med201025327328120830224
- InzucchiSEBergenstalRMBuseJBManagement of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of DiabetesDiabetes Care201538114014925538310
- LandgrafRKellererMFachEPraxisempfehlungen DDG/DGIMDiabetologie Stoffwechsel20138Suppl 2S146S158
- HolmanRRPaulSKBethelMAMatthewsDRNeilHA10-year follow-up of intensive glucose control in type 2 diabetesN Engl J Med2008359151577158918784090
- StettlerCAllemannSJüniPGlycemic control and macro-vascular disease in types 1 and 2 diabetes mellitus: metaanalysis of randomized trialsAm Heart J20061521273816824829
- RydenLStandlEBartnikMGuidelines on diabetes, prediabetes, and cardiovascular disease: executive summaryEur Heart J20072818813617220161
- FritscheALarbigMOwensDHäring H-U; on behalf of the GINGER Study GroupComparison between a basal-bolus and a premixed insulin regimen in individuals with type 2 diabetes – results of the GINGER studyDiabetes Obes Metab201012211512320092584
- DaikelerRHögyBDonaubauerBEffects of an intensified insulin therapy (BBT) with insulin glargine and insulin glulisine on patient reported outcomes (PRO) in diabetes mellitusDiabetologie Stoffwechsel200725308314
- Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF)Nationale VersorgungsLeitlinie Therapie des Typ-2-Diabetes – Langfassung, 1. Auflage. Version 22013 [last changed: April 2014]. Available from: http://www.versorgungsleitlinien.de/themen/diabetes2/dm2_TherapieAccessed July 25, 2015
- SiegmundTWeberSBlankenfeldHOeffnerASchumm-DraegerPMComparison of insulin glargine versus NPH insulin in people with type 2 diabetes mellitus under outpatient-clinic conditions for 18 months using a basal-bolus regimen with a rapid-acting insulin analogue as mealtime insulinExp Clin Endocr Diabetes20071156349353
- DonaubauerBFerlinzKSchreiberSCombining insulin glulisine with basal insulin glargine provides improved glycaemic control in patients with type 2 diabetes in everyday clinical practiceDiabet Med200825Suppl 148 Abstr P42
- SchreiberSALandgrafWBöhlerSEfficacy and tolerability of insulin glargine in BBTDiabetes Stoffw Herz20091829198
- OwensDRLuzioSDSert-LangeronCRiddleMCEffects of initiation and titration of a single pre-prandial dose of insulin glulisine while continuing titrated insulin glargine in type 2 diabetes: a 6-month ‘proof of concept’ studyDiabetes Obes Metab201113111020102721679291
- SchreiberSAFiesselmannABornsteinSRLandgrafWInsulin analogues insulin glargine and insulin glulisine in type 1 diabetesDiabetes Stoffw Herz20112026977
- GotoAArahOAGotoMTerauchiYNodaMSevere hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysisBMJ2013347f453310.1136/bmj.f4533 Available from: http://www.isdbweb.org/documents/file/5293c692ca507.pdfAccessed July 25, 201423900314
- HanefeldMDuettingEBramlagePCardiac implications of hypoglycaemia in patients with diabetes – a systematic reviewCardiovasc Diabetol20131213510.1186/1475-2840-12-135 Available from: http://www.cardiab.com/content/pdf/1475-2840-12-135.pdfAccessed July 25, 201424053606
- PerkJDe BackerGGohlkeHEuropean guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention and Rehabilitation (EACPR)Eur Heart J2012331635170122555213
- GersteinHCBoschJDagenaisGRBasal insulin and cardiovascular and other outcomes in dysglycemiaN Engl J Med2012367431932822686416
- HanefeldMBramlagePInsulin Use early in the course of type 2 diabetes mellitus: the origin trialCurr Diab Rep20131334234923397557